Literature DB >> 20696027

Role of MICA in the immune response to transplants.

Y Zou1, P Stastny.   

Abstract

Among the cell surface antigens that can elicit an immune response in transplant recipients MICA antigens occupy a special place. They are similar to human leukocyte antigens (HLAs) while being very different from them. They are not as polymorphic and their quantity is smaller. In consequence, the impact of MICA antigens in transplantation is not as dramatic. However, our early guess that these ligands of NKG2D could elicit antibodies and cell-mediated immunity has been definitely confirmed. Careful analysis with MICA transfectant cells, for absorption and elution, established the specificity of the epitopes involved. Typing of recipients and donors by sequencing the MICA alleles has established that de novo antibodies produced in kidney transplant recipients are directed at mismatched MICA epitopes and are associated with acute rejection and chronic transplant failure. Acute graft-versus-host disease was observed in stem cell recipients who were mismatched for MICA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696027     DOI: 10.1111/j.1399-0039.2010.01527.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Medhat Askar; Ronald Sobecks; Tao Wang; Mike Haagenson; Navneet Majhail; Abeer Madbouly; Dawn Thomas; Aiwen Zhang; Katharina Fleischhauer; Katharine Hsu; Michael Verneris; Stephanie J Lee; Stephen R Spellman; Marcelo Fernández-Viña
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-14       Impact factor: 5.742

2.  Studies on the antigenicity of the NKG2D ligand H60a in tumour cells.

Authors:  Deepak Yadav; Jennifer Ngolab; Natalie Dang; Jack D Bui
Journal:  Immunology       Date:  2011-03-25       Impact factor: 7.397

3.  Immune responses to self-antigens (autoimmunity) in allograft rejection.

Authors:  Sabarinathan Ramachandran; Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Clin Transpl       Date:  2012

4.  Acute Antibody-Mediated Rejection in Presence of MICA-DSA and Successful Renal Re-Transplant with Negative-MICA Virtual Crossmatch.

Authors:  Yingzi Ming; Juan Hu; Qizhi Luo; Xiang Ding; Weiguang Luo; Quan Zhuang; Yizhou Zou
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

5.  The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.

Authors:  Antje Isernhagen; Dörthe Malzahn; Elena Viktorova; Leslie Elsner; Sebastian Monecke; Frederike von Bonin; Markus Kilisch; Janne Marieke Wermuth; Neele Walther; Yesilda Balavarca; Christiane Stahl-Hennig; Michael Engelke; Lutz Walter; Heike Bickeböller; Dieter Kube; Gerald Wulf; Ralf Dressel
Journal:  EMBO Mol Med       Date:  2015-11       Impact factor: 12.137

6.  Prenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial Cells.

Authors:  Caroline Rouger; Sylvain Pagie; Séverine Derbré; Anne-Marie Le Ray; Pascal Richomme; Béatrice Charreau
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

7.  Over-shedding of donor-derived cell-free DNA at immune-related regions into plasma of lung transplant recipient.

Authors:  Jiaqi Luo; Liping Liu; Lingxi Chen; Xin Xu; Yanfei Wang; Bing Wei; Chunrong Ju; Xuedong Wang; Liyan Huang; Wenchuang Zeng; Xinyao Miao; Ling Sang; Danxia Huang; Guangze Pan; Guilin Peng; Zhuxing Chen; Zicheng Zhao; Chao Yang; Weixue Cui; Wenxi Jiang; Jinjin Xu; Shuai Cheng Li; Jianxing He
Journal:  Clin Transl Med       Date:  2022-01

Review 8.  Genetic barriers in transplantation medicine.

Authors:  Hisham A Edinur; Siti M Manaf; Nor F Che Mat
Journal:  World J Transplant       Date:  2016-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.